New weight loss pill approved for use in UK
The UK has become the first European country to approve 'Foundayo,' a daily weight-loss pill developed by Eli Lilly for obesity and type 2 diabetes. While currently available for private purchase, the drug's potential for NHS use is still under review.
Why it matters
The introduction of an oral weight-loss medication offers a more convenient and potentially cheaper alternative to existing injectable treatments.
Share Save Add as preferred on Google Nick Triggle Health correspondent Getty Images A daily weight-loss pill made by the drug firm behind the Mounjaro jab has been approved for use in the UK - the first country in Europe to do so.
Foundayo, made by Eli Lilly, is for treating obesity and type 2 diabetes.
But while people will be able to buy it privately with a prescription, the approval by the Medicines and Healthcare productors Regulatory Agency does not automatically mean it will be made available on the NHS.
Foundayo is a form of GLP-1 medication that blunts appetite, and comes after the MHRA approved a pill version of a similar weight-loss drug, Wegovy, in June.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in